Reports for TEVA CANADA LIMITED
Formerly known as ACTAVIS PHARMA COMPANY
Company Name
TEVA CANADA LIMITED
Shortage reports
Actual shortage:
214 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
2706 (92%)
2930
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
298 (99%)
Reversed:
0 (0%)
300
363 (11%)
103 (48%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-CITALOPRAM | 40MG | TABLET | Resolved | 2021-07-15 | 2022-02-17 | 142622 |
| TEVA-CITALOPRAM | 20MG | TABLET | Resolved | 2024-07-11 | 2024-07-18 | 232744 |
| TEVA-CITALOPRAM | 10MG | TABLET | Resolved | 2021-01-22 | 2021-06-03 | 132288 |
| TEVA-CITALOPRAM | 20MG | TABLET | Resolved | 2020-09-24 | 2021-01-07 | 124965 |
| TEVA-CITALOPRAM | 20MG | TABLET | Resolved | 2020-10-22 | 2021-01-07 | 126939 |
| TEVA-CITALOPRAM | 10MG | TABLET | Resolved | 2025-03-06 | 2025-05-02 | 252081 |
| TEVA-CITALOPRAM | 10MG | TABLET | Resolved | 2022-01-07 | 2022-01-13 | 152411 |
| TEVA-CITALOPRAM | 40MG | TABLET | Resolved | 2021-01-22 | 2021-06-03 | 132285 |
| TEVA-CITALOPRAM | 20MG | TABLET | Resolved | 2017-08-21 | 2017-10-10 | 19934 |
| TEVA-CITALOPRAM | 20MG | TABLET | Resolved | 2018-03-16 | 2018-05-30 | 43129 |
| TEVA-CITALOPRAM | 20MG | TABLET | Resolved | 2021-01-22 | 2021-06-03 | 132282 |
| TEVA-CITALOPRAM | 20MG | TABLET | Resolved | 2025-04-10 | 2025-04-24 | 254792 |
| TEVA-CITALOPRAM | 40MG | TABLET | Resolved | 2017-08-01 | 2017-09-19 | 17874 |
| TEVA-CITALOPRAM | 20MG | TABLET | Resolved | 2020-03-26 | 2020-05-08 | 109613 |
| TEVA-CITALOPRAM | 40MG | TABLET | Resolved | 2024-08-08 | 2024-10-17 | 234888 |
| TEVA-CITALOPRAM | 10MG | TABLET | Resolved | 2021-11-18 | 2022-01-07 | 149609 |
| TEVA-CLARITHROMYCIN | 500MG | TABLET | Resolved | 2020-03-06 | 2020-06-11 | 108024 |
| TEVA-CLARITHROMYCIN | 250MG | TABLET | Resolved | 2020-03-06 | 2020-06-11 | 108021 |
| TEVA-CLINDAMYCIN | 150MG | CAPSULE | Resolved | 2020-08-20 | 2021-01-28 | 122702 |
| TEVA-CLINDAMYCIN | 150MG | CAPSULE | Resolved | 2017-04-03 | 2017-05-10 | 5177 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| METHOTREXATE SODIUM INJECTION | 25MG | SOLUTION | Discontinued | 2025-04-25 | 2025-04-25 | 255818 |
| METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION | 40MG | POWDER FOR SOLUTION | Discontinued | 2021-09-23 | 2021-09-23 | 146061 |
| NOVAMOXIN | 500MG | CAPSULE | Discontinued | 2017-06-27 | 2017-06-27 | 14046 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Discontinued | 2019-04-11 | 2019-04-11 | 81316 |
| NOVAMOXIN | 25MG | GRANULES FOR SUSPENSION | Discontinued | 2019-04-11 | 2019-04-11 | 81393 |
| NOVAMOXIN | 125MG | TABLET (CHEWABLE) | Discontinued | 2019-04-11 | 2019-04-11 | 81321 |
| NOVAMOXIN | 250MG | CAPSULE | Discontinued | 2020-01-24 | 2020-01-24 | 104289 |
| NOVAMOXIN | 125MG | TABLET (CHEWABLE) | Discontinued | 2019-10-25 | 2019-10-26 | 97251 |
| NOVASEN | 650MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63964 |
| NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63955 |
| NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63959 |
| NOVO-PROFEN | 200MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81310 |
| NOVO-PROFEN | 400MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64920 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-19 | 2018-10-19 | 64852 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 |